Dr. Reddy’s Laboratories said that it has launched Venlafaxine ER Tablets, which is therapeutically equivalent to Osmotica Pharmaceutical US’ Venlafaxine Extended-Release Tablets, 150 mg and 225 mg.

Approved by the US Food and Drug Administration (FDA), Venlafaxine is indicated for the treatment of depression.

According to IQVIA Health, the brand and generic had sales of around $51 million moving annual total (MAT) in the US for the most recent 12 months ending in October 2021.

Dr. Reddy’s Laboratories said that Venlafaxine ER Tablets are available in strengths of 150 mg and 225 mg in bottle count sizes of 30 and 90.

  Depression, Dr. Reddy’s Laboratories, Osmotica Pharmaceutical, USA, Venlafaxine ER Tablets, Venlafaxine Extended-Release Tablets